Canopy Study Selected for Oral Presentation at ASH 2025
Study shows potential of Canopy’s Remote Therapeutic Monitoring Platform to reduce infection-related hospitalizations and ER visits in patients treated for hematological malignancy New York, New York - Canopy, the leader in Enterprise AI for oncology, today announced findings on the potential of its EHR-integrated Remote Therapeutic Monitoring (RTM) Platform to reduce infection-related hospitalization in patients receiving treatment for hematologic malignancies, through earlier identification of infection-related symptoms and associated initiation of outpatient oral antibiotics.
Read more






